| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| 10mg |
|
||
| 50mg |
|
||
| Other Sizes |
|
| ln Vitro |
TP pins (IC50=742 nM), EP1 (IC50=486 nM), and DP1 (IC50=131 nM) make up DG-041[1].
|
|---|---|
| ln Vivo |
DG-041, administered intravenously at 1.78 mg/kg or bucally at 9.62 mg/kg, had a t1/2 of 2.7 hours and a Cmax of 2.74 μM and 9.46 μM, respectively. 1250 mL/h/kg is the intravenous injection CL [
|
| Animal Protocol |
Animal/Disease Models: Male Sprague Dawley rat [1]
Doses: 1.78 mg/kg (intravenous) or 9.62 mg/kg (oral) Route of Administration: intravenous (iv) (iv)or oral Experimental Results: t1/2 is 2.7 hrs (hrs (hours)), 4.06 hrs (hrs (hours)) and Cmax is 9.46 1]. intravenous (iv) (iv)injection and oral administration are μM and 2.74 μM respectively. |
| References |
|
| Molecular Formula |
C23H15CL4FN2O3S2
|
|---|---|
| Molecular Weight |
592.3
|
| Exact Mass |
589.926
|
| CAS # |
861238-35-9
|
| PubChem CID |
11296282
|
| Appearance |
Light yellow to green yellow solid powder
|
| LogP |
9.251
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
5
|
| Rotatable Bond Count |
6
|
| Heavy Atom Count |
35
|
| Complexity |
908
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
CC1=CN(C2=C(C=C(C=C12)F)/C=C/C(=O)NS(=O)(=O)C3=CC(=C(S3)Cl)Cl)CC4=C(C=C(C=C4)Cl)Cl
|
| InChi Key |
BFBTVZNKWXWKNZ-HWKANZROSA-N
|
| InChi Code |
InChI=1S/C23H15Cl4FN2O3S2/c1-12-10-30(11-14-2-4-15(24)7-18(14)25)22-13(6-16(28)8-17(12)22)3-5-20(31)29-35(32,33)21-9-19(26)23(27)34-21/h2-10H,11H2,1H3,(H,29,31)/b5-3+
|
| Chemical Name |
(E)-3-[1-[(2,4-dichlorophenyl)methyl]-5-fluoro-3-methylindol-7-yl]-N-(4,5-dichlorothiophen-2-yl)sulfonylprop-2-enamide
|
| Synonyms |
DG041; DG 041; DG-041
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~250 mg/mL (~422.07 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (3.51 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.6883 mL | 8.4417 mL | 16.8833 mL | |
| 5 mM | 0.3377 mL | 1.6883 mL | 3.3767 mL | |
| 10 mM | 0.1688 mL | 0.8442 mL | 1.6883 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
